Magic mushrooms lift severe depression in clinical trial

5/26/2016

This article discusses a clinical trial that explored the potential of magic mushrooms to treat severe depression. The trial involved giving participants a single dose of psilocybin, the active compound in magic mushrooms, along with psychological support. The results showed that the majority of participants experienced a significant reduction in depressive symptoms, with some experiencing a complete remission. The article also delves into the mechanism of action of psilocybin and how it differs from traditional antidepressant medications. It highlights the need for further research in this area to fully understand the potential benefits and risks of using magic mushrooms as a treatment for depression.

psilocybin ꞏ magic mushrooms ꞏ depression treatment ꞏ mental health ꞏ clinical trials ꞏ psychedelic therapy ꞏ hallucinogens ꞏ therapeutic effects ꞏ serotonin ꞏ brain chemistry ꞏ mood disorders ꞏ psychedelic research ꞏ alternative medicine ꞏ mental illness ꞏ psychoactive substances ꞏ serotonin receptors ꞏ neurobiology ꞏ psychiatric treatment ꞏ psychiatric disorders ꞏ pharmacology ꞏ psychedelic-assisted therapy ꞏ mental wellbeing ꞏ psychedelic drugs ꞏ mood enhancement ꞏ therapeutic potential ꞏ psychedelic experiences ꞏ psychedelic substances ꞏ psychedelic medicine ꞏ emotional healing ꞏ consciousness exploration ꞏ therapeutic psychedelics ꞏ mental health breakthrough